The Clorox Company (NYSE:CLX) Shares Purchased by Southland Equity Partners LLC

Southland Equity Partners LLC raised its holdings in shares of The Clorox Company (NYSE:CLX) by 51.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,741 shares of the company’s stock after buying an additional 1,618 shares during the period. Southland Equity Partners LLC’s holdings in Clorox were worth $770,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Insight Folios Inc grew its position in Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after buying an additional 63 shares during the last quarter. HCR Wealth Advisors grew its holdings in shares of Clorox by 1.0% in the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after acquiring an additional 68 shares during the last quarter. SPC Financial Inc. raised its position in shares of Clorox by 2.2% during the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after purchasing an additional 75 shares during the period. Massmutual Trust Co. FSB ADV lifted its holdings in shares of Clorox by 17.2% during the third quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after purchasing an additional 75 shares during the last quarter. Finally, Empower Advisory Group LLC boosted its position in shares of Clorox by 4.5% in the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after purchasing an additional 78 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Price Performance

Shares of CLX opened at $160.81 on Friday. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The firm has a market cap of $19.90 billion, a PE ratio of 56.03, a PEG ratio of 2.92 and a beta of 0.42. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The firm’s 50 day moving average price is $163.93 and its 200 day moving average price is $157.11.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.49 EPS. As a group, research analysts expect that The Clorox Company will post 6.87 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.03%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is 170.04%.

Wall Street Analysts Forecast Growth

CLX has been the subject of a number of analyst reports. DA Davidson upped their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research note on Thursday, January 16th. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $155.00 to $157.00 in a research report on Tuesday, January 7th. Finally, Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Hold” and an average price target of $156.54.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.